Nevertheless, non-invasive
prenatal testing has brought a paradigm shift in prenatal genetic diagnosis, which aims to detect fetal aneuploidies such as trisomies 18, 13, 21 through the assessment of cell-free DNA (cfDNA).
New Report on United States Non-Invasive
Prenatal Testing Market 2019 Edition
"Is it licit to hire a hitman to resolve a problem?" He also denounced decisions to abort based on
prenatal testing, saying a human being is "never incompatible with life".
Elucigene's current product portfolio is complementary to Yourgene's existing non-invasive
prenatal testing solutions, broadening the offering of the enlarged group as a provider of molecular diagnostic solutions for reproductive health.
Sofiva Genomics, which provides services spanning
prenatal testing, neonatal testing, personalized care, as well as screening for cancer and rare genetic diseases, will be setting up a laboratory in the capital of Thailand, according to a press release by the company.
Generally, non-invasive
prenatal testing, or NIPT, analyzes cell-free DNA, or cfDNA, circulating in the maternal blood and has rapidly become the standard follow-up procedure for women classified as high risk following traditional prenatal screening.
It was fronted by Sally Phillips, a popular actress and mother of a son with Down syndrome who set out to critique the use of noninvasive
prenatal testing (NIPT) for fetal anomaly and, more specifically, to probe the ethical questions surrounding a decision to terminate when Down syndrome is detected.
The non-invasive
prenatal testing (NIPT) will be offered to women who have taken up the initial offer of screening and are found to be at a higher risk of the three conditions.
In the first case, described in 2013, a 37-year-old woman underwent noninvasive
prenatal testing (NIPT) at 13 weeks of gestation and received a test report of "aneuploidy detected, trisomy 13 and monosomy 18" (7).
Non-invasive
prenatal testing or screening (NIPT/NIPS) using cell-free DNA (cfDNA) has been commercially available for over five years.
28 July 2017 - Luxembourg-based bio-analytical testing provider Eurofins Scientific (EUFI.PA) (Paris: ERF), has finalised the acquisition of a stake in Germany based
prenatal testing specialists GATC Biotech AG, the company said.